NewTimeSpace News: Zhongan Information Technology (Shenzhen) Co., Ltd. submitted a listing application to HKEX on 24 July, with ICBC International and Guolian Securities International acting as joint sponsors. The Company is an enterprise-focused AI solution provider. Its cumulative client base expanded from 88 at end-2023 to 361 at end-2025, representing a compound annual growth rate of 102.5%, and further rose to 409 as at 31 May 2026.
NewTimeSpace News: Guangzhou Novaken Pharm Co., Ltd. submitted its second listing application to the Hong Kong Stock Exchange on 24 July, with Guotai Junan International acting as the sole sponsor. Founded in 2007, it is a clinical-stage pharmaceutical enterprise focusing on the development and commercialisation of improved new drugs. Its core product DHMP (Dexmedetomidine Hydrochloride Microneedle Patch) is China’s first dissolvable microneedle pharmaceutical patch approved for clinical trials and the only candidate progressing into Phase II clinical studies to date. Another core asset XJN010 is the first investigational product targeting off episodes of Parkinson’s Disease to secure clinical trial approval in China.
NewTimeSpace News: According to HKEX disclosures, the GEM listing application of Changle Holdings Limited submitted on 23 January 2026 has recently lapsed upon expiry of the six-month validity period. Legend Corporate Finance Limited acted as the sole sponsor at the time of filing. The Company is a Singapore-incorporated general contractor undertaking construction and renovation works, holding a GB1 licence issued by the Building and Construction Authority.
NewTimeSpace News: According to HKEX filings, the Main Board listing application of Zhejiang IPLUSMOBOT Technology Co., Ltd. submitted on 23 January 2026 has recently lapsed upon the expiry of the six-month validity period. CICC acted as the sole sponsor at the time of submission. According to CIC Consulting, measured by order value, the Company ranks among the world’s top 10 intelligent mobile robot suppliers, top five globally and top three in China within the industrial intelligent mobile robot segment.
NewTimeSpace News: According to HKEX disclosures, the Main Board listing application of Dizal (Jiangsu) Pharmaceutical Co., Ltd., submitted on 23 January 2026, has recently lapsed upon expiry of the six-month validity period. Goldman Sachs and Huatai International acted as joint sponsors at the time of filing. The Company is a commercial-stage biopharmaceutical firm. Its flagship product ZEGFROVY® is the world’s only approved small-molecule targeted drug for the treatment of EGFR exon 20 insertion mutation lung cancer.
NewTimeSpace News: The listing application of Shanghai Junyi Industrial Automation Co., Ltd. submitted to HKEX on 23 January 2026 has lapsed upon expiry of the six-month validity period. Guotai Junan International acted as the original sole sponsor. The Company is a well-known mainland China integrator of robotic automation systems and solutions, supplying smart manufacturing solutions to global automotive manufacturing and new energy battery industries, with customers covering markets including China, Germany, the United States, France, the United Kingdom, Spain and multiple other regions.
NewTimeSpace News: Leadrive Technology (Shanghai) Co., Ltd. resubmitted its listing application to HKEX on 22 July, with CITIC Securities and Haitong International acting as joint sponsors. The Company is a technology-driven supplier of electric drive control solutions focusing on new energy passenger vehicles. According to Frost & Sullivan, measured by 2025 sales revenue, the Company ranks No.1 in China for dual-motor controllers and primary drive power bricks. It has secured 59 project nominations from 15 OEMs, with its solutions deployed across 92 vehicle models.
NewTimeSpace News: Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. filed its listing application with HKEX on 22 July, with CICC and Sinolink Securities (Hong Kong) acting as joint sponsors. According to Frost & Sullivan, measured by 2025 revenue, the Company is China’s largest provider of temperature-controlled supply chain services for pharmaceutical and life science industries, and the only Chinese enterprise among the world’s top ten service providers for clinical trial temperature-controlled supply chains, serving over 7,000 clients.
NewTimeSpace News: Guangxi Baifei Dairy Co., Ltd. submitted its listing application to HKEX on 22 July, with GF Securities acting as sole sponsor. The Company is a leading Chinese buffalo dairy player. Its core brand Baifei Luoranks No.1 in China’s buffalo dairy industry with a 30.1% market share. According to Frost & Sullivan, the Group commands a 31.0% share of liquid buffalo milk market, 31.8% of ambient liquid buffalo milk market and 39.1% of online liquid buffalo milk sales, claiming top position in all three segments.
NewTimeSpace News: The listing application of Hangzhou Bangshun Pharmaceutical Co., Ltd. submitted to HKEX on 22 January 2026 has lapsed upon expiry of the six-month validity period. China Securities International served as the original sole sponsor. The Company is a biotech firm nearing commercialisation, focusing on oncology and autoimmune diseases. Its core asset Bezacitinib is expected to become one of the first three domestically developed JAK inhibitors approved in China, ranking No.1 in clinical progress nationwide for the indication of polycythemia vera.
NewTimeSpace News: The listing application of Shanghai A&I Co., Ltd. submitted to HKEX on 22 January 2026 has lapsed upon the expiry of the six-month validity period. Orient Securities International acted as the original sole sponsor. The Company is a leading provider of integrated intelligent manufacturing system solutions in China. By integrating artificial intelligence technology and manufacturing engineering capabilities, it delivers one-stop intelligent solutions covering automotive, communications, robotics, new energy and other sectors. According to Frost & Sullivan, based on 2024 revenue, the Company ranks No.1 in China for automotive driveshaft equipment, top four for brake-by-wire equipment and automotive differential equipment, and top seven for communication base station thermal modules.
NewTimeSpace News: ZHONGJI INNOLIGHT (03308.HK) launches its public offering on 22 July. Each board lot comprises 50 shares with an entry cost of approximately HK$51,009. The Company proposes a global offering of 54.5 million H Shares at a maximum offer price of HK$1,010 per share, with listing scheduled for 30 July. Cornerstone investors commit approximately US$3.45 billion (around HK$27.04 billion). Based on the maximum offer price, they will subscribe for roughly 26.7722 million H Shares, representing 49.12% of the global offering H Shares.
NewTimeSpace News: Silicon-Magic Semiconductor Technology (Hangzhou) Co., Ltd. refiled its listing application with HKEX for the third time on 20 July, with Huatai International acting as sole sponsor. A power semiconductor player adopting the Virtual IDM model, the Company delivers high-efficiency power management solutions via proprietary process technologies. Its product portfolio covers mobile, display and power device segments, widely deployed in automotive, data center (including AI servers), industrial and consumer electronics applications.
NewTimeSpace News: TOPSTAR refiled its listing application with HKEX on 20 July, with Huatai International acting as sole sponsor. Per Frost & Sullivan data, the Group has developed mainland China’s first intelligent humanoid robot deployed in injection molding scenarios and been designated as the Chain Leader Enterprise of Guangdong’s intelligent robot industrial chain by Guangdong authorities.
NewTimeSpace News: The HKEX listing application of Beijing DELTAPHONE TECHNOLOGY CO., LIMITED, filed on 20 January 2026, has expired upon the end of the six-month validity term, with SUNNY FORTUNE as the original sole sponsor. According to Frost & Sullivan, ranked by FY2024 revenue, the Group is China’s fifth-largest independent professional AIoT service provider with a market share of around 1.8%, and the third-largest independent professional AIoT service provider serving China’s energy sector with a market share of roughly 9.9%.
NewTimeSpace News: The HKEX listing application of Shenzhen WOKE TECHNOLOGY Co., Ltd., filed on 20 January 2026, has expired upon the lapse of the 6-month validity period. Huatai International acted as the original sole sponsor. As a Southeast Asia-focused cross-border new retail operator empowered by full-link digital capabilities, it is the top Chinese cross-border player in Indonesia’s 3C accessories segment by retail sales value in 2024.
